Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Raj Parekh
Age : 60
Public asset : 30,592 USD
Country of residence : Unknown
Linked companies : Galapagos NV - Aura Biosciences, Inc.

Biography of Raj Parekh 
Dr. Raj B. Parekh is an Independent Director at Eloxx Pharmaceuticals, Inc., a General Partner at Advent Life Sciences LLP, a Chairman at Galapagos NV and a Professor at University of Oxford. He is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Arrakis Therapeutics, Inc., Capella Bioscience Ltd., Advent LS Services Ltd., Aleta Biotherapeutics, Inc., Aleta, Inc., Alpha Anomeric SA, Alpha Anomeric SAS, Amphista Therapeutics Ltd., Arrakis, Inc., Artax, Inc., Aura Biosciences, Inc., Aura, Inc., Cellnovo Ltd., Itara Ltd., Levicept Ltd., Performance Electronics Ltd., Project Paradise Ltd., Rappta Therapeutics Oy, Tridek-One Therapeutics SAS, Zikani Therapeutics, Inc., Novartis Venture Fund and Biocartis SA. Dr. Parekh was previously employed as a General Partner by Advent Venture Partners LLP, a Non-Executive Chairman by Chroma Therapeutics Ltd., a CEO, Chief Scientific Officer & Senior VP-Research by Oxford GlycoSciences Plc, a Director-Supervisory Board by 4-Antibody AG, a Non-Executive Director by Biocartis Group NV, a Chief Executive Officer & Director by Biocartis SA, a Chairman by CoCo Therapeutics Ltd., a Non-Executive Director by EUSA Pharma, Inc., a Non-Executive Director by F2G Ltd., and a Non-Executive Director by Jazz Pharmaceuticals UK Ltd. He also served on the board at Cellnovo Group SA, AVANT Immunotherapeutics, Inc., Celldex Therapeutics, Inc., Celldex Research Corp., Amsterdam Molecular Therapeutics (AMT) Holding NV, Artax Biopharma, Inc., Avant! Corp. (California), Avila Therapeutics, Inc., Biocartis NV, Luxfold S.A., NeRRe Therapeutics Ltd. and Thiakis Ltd. He received his undergraduate degree from the University of Oxford, a graduate degree from the University of Oxford and a doctorate degree from the University of Oxford.


Current positions of Raj Parekh 
Raj Parekh : Personal Network 
Most Read News 
07/27AMANCIO ORTEGA : Inditex founder Ortega buys 5% in Enagas's renewable, hydrogen unit
RE
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/26MARK ZUCKERBERG : As Zuckerberg bets on TikTok-style videos, Meta heads for first-ever revenue drop
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
07/26ELON MUSK : Elon Musk asks judge for Twitter trial on Oct. 17, not Oct. 10
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
07/25Morgan Stanley's institutional equities head David Russell to retire
RE
More news


© 2022 People and Ownership :   
Raj Parekh : Connections 


Latest news about Raj Parekh 
01/26Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
RE
2021TRANSCRIPT : Eloxx Pharmaceuticals, Inc., Zikani Therapeutics, Inc. - M&A Call
CI
2021Eloxx Pharmaceuticals, Inc. acquired Zikani Therapeutics, Inc. for $25.2 million.
CI
2020Galapagos NV Approves the Appointment of Elisabeth Svanberg and Raj Parekh as Director
CI
More news